Carlsmed (CARL) closed at $14.64 on Oct 6, 2026, down 4.3% on the day. The stock is down 6.2% over the past month, up 20.9% over three months, up 18.5% year to date and up 12.9% over the past year. It trades 15.0% below its 52-week high of $17.23 and 72.2% above its 52-week low of $8.50. The close sits below its 50-day moving average ($14.77) and above its 200-day moving average ($12.27).
Yes — the Oct 6, 2026 close of $14.64 is 19.3% above the 200-day average of $12.27.
CARL closed 15.0% below its 52-week high of $17.23.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
